R&D share of pharmaceutical direct economic contribution
RecordSTO-NZNKFES3X8-00FM9VC6A0-3C4RNW
Global · 2022
R&D share of pharmaceutical direct economic contribution worldwide was 30% in 2022 (IFPMA).
R&D share of pharmaceutical direct economic contribution: every country and year, and how it is measured
- Publisher
- IFPMA
- Authority tier
- T2 Official
- Retrieved
- 15 Sep 2026
- Status
- Verified
What the source says
In 2022, the pharmaceutical sector’s R&D activities alone contributed USD 227 billion GDP globally, 30% of its direct contribution to the world economy.
Checked: the figure 30%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
IFPMA. (2022). Enabling innovation: The R&D ecosystem for medicines and vaccines. Retrieved September 15, 2026, from https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Via StatOrigin, https://statorigin.org/stat/stat_NZNKFES3X800FM9VC6A03C4RNW
Other formats: MLA, Chicago, BibTeX
- MLA
- IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2022, https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_NZNKFES3X800FM9VC6A03C4RNW.
- Chicago
- IFPMA. "Enabling innovation: The R&D ecosystem for medicines and vaccines." 2022. https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_NZNKFES3X800FM9VC6A03C4RNW.
- BibTeX
- @misc{ifpma2022share3c4rnw, author = {{IFPMA}}, title = {Enabling innovation: The R\&D ecosystem for medicines and vaccines}, year = {2022}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_NZNKFES3X800FM9VC6A03C4RNW}, note = {Original source: https://www.ifpma.org/publications/enabling-innovation-the-rd-ecosystem-for-medicines-and-vaccines/. Accessed September 15, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- IFPMA · homepage ↗
- Authority tier
- Tier 2 · National and industry official
- Report
- Enabling innovation: The R&D ecosystem for medicines and vaccines
- Type
- Press release
- Published
- —
- Locator
- Enabling innovation: The R&D ecosystem for medicines and vaccines
- Retrieved
- 15 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_NZNKFES3X800FM9VC6A03C4RNW